US Biomaterials Access Act signed into law
This article was originally published in Clinica
President Clinton has signed the Biomaterials Access Assurance Act of 1998 which protects biomaterial suppliers from being included in potentially costly lawsuits over faulty implants.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.